Archive for May, 2010
Next Entries »Soluble fiber improves multiple CV risk markers in hypercholesterolemia
Thursday, May 6th, 2010Daily consumption of soluble fiber improves a broad range of cardiometabolic parameters in people with hypercholesterolemia, a randomized trial has demonstrated.
The study authors propose that Plantago ovate-derived “Po-husk” could be a useful adjunctive therapy in people with multiple risk factors for cardiovascular disease, such as those with the metabolic syndrome.
A multinational research team led by Rosa [...]
Early dual antiplatelet therapy cuts microemboli risk after cerebral stenosis
Wednesday, May 5th, 2010Source: MedWire News
Early combination antiplatelet therapy results in fewer microemboli relative to aspirin monotherapy in patients with symptomatic cerebral or carotid artery stenosis, show results of the CLAIR study.
“Clinical trials are now warranted to investigate whether this combination treatment also results in a reduction in stroke incidence,” write the CLAIR (Clopidogrel plus aspirin versus aspirin [...]
Lamotrigine May Be Most Effective Antiepileptic Drug For Older Adults.
Wednesday, May 5th, 2010Medscape (5/4, Barclay) reported, “Lamotrigine is the most effective antiepileptic drug (AED) in older adults with epilepsy, with levetiracetam a close second, according to the results of a retrospective review of 10 AEDs reported in the April issue of the Archives of Neurology.” The study compared “the effectiveness of AEDs in [...]
Statins linked with reduced AF incidence in CAD patients
Tuesday, May 4th, 2010Source: MedWire News
Statin therapy is associated with a reduced risk for new-onset atrial fibrillation (AF) in patients who have been hospitalized for coronary artery disease (CAD), a large cohort study suggests.
In the study of nearly 30,000 Medicare beneficiaries, statin use was independently associated with a lower risk for AF, supporting a potential anti-arrhythmic effect of [...]
